FrancophonIA/ELRC3.0 huggingface dataset:
English: If you get any side effects, talk to your doctor or pharmacist.
Slovenian: Če opazite katerega koli izmed neželenih učinko, se posvetujte z zdravnikom ali farmacevtom.
English: Diarrhoea, flatulence, abdominal pain
Slovenian: Zelo pogosto driska, flatulenca, bolečine v trebuhu
English: Common side effects of treatment include headache, dizziness, paraesthesia (tingling or numbness), abnormal coordination, hypoaesthesia (reduced sensation to touch), dyspepsia (heartburn), nausea (feeling sick), constipation and vomiting, swelling or discomfort in the abdomen (stomach) and thrombocytopenia (reduced levels of blood platelets).The neurological symptoms and thrombocytopenia could be due to the underlying disease.
Slovenian: Pogosti neželeni učinki - pojavijo se lahko pri največ 1 od 10 bolnikov Pogosti neželeni učinki vključujejo glavobol, omotičnost, parestezije (mravljinčenje ali omrtvičenost), nenormalno koordinacijo, hipoestezijo (zmanjšana zmožnost čutenja na dotik), dispepsijo (zgago), navzejo (slabost), zaprtje in bruhanje, oteklost trebuha ali nelagodje v trebuhu in trombocitopenijo
English: He or she may reduce the dose of Yargesa or recommend other medicines to help control side effects.
Slovenian: Kadar neželeni učinki povzročajo skrbi ali neprijetnosti, se posvetujte z zdravnikom, ki vam bo morda znižal odmerek zdravila Yargesa ali za nadzor nad neželenimi učinki priporočil druga zdravila.
English: Mild reductions in platelet counts without association with bleeding were observed in patients with type 1 Gaucher disease who were switched from ERT to miglustat.
Slovenian: Pri bolnikih z Gaucherjevo boleznijo tipa 1, ki so prešli iz zdravljenja z ERT na miglustat, so opazili blago zmanjšanje števila trombocitov, ki ni bilo povezano s krvavitvami.
English: Fatigue, asthenia, chills and malaise
Slovenian: Pogosto utrujenost, astenija, mrzlice in splošno slabo počutje
English: The pivotal trial of miglustat was conducted in patients unable or unwilling to receive ERT. Reasons for not receiving ERT included the burden of intravenous infusions and difficulties in venous access.
Slovenian: Ključno preskušanje miglustata so opravili pri bolnikih, ki se niso mogli ali hoteli zdraviti z ERT.
English: Miglustat has been used in clinical trials at doses ten times higher than the recommended dose: this caused decreases in white blood cells and other side effects similar to those described in section 4.
Slovenian: V kliničnih preizkušanjih so miglustat jemali v odmerkih, ki so bili 10-krat višji kot priporočeni odmerek.
English: Dosage
Slovenian: Dojenje
English: CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
Slovenian: D. POGOJI ALI OMEJITVE V ZVEZI Z VARNO IN
English: Therapy should be directed by physicians who are knowledgeable in the management of Gaucher disease or Niemann-Pick type C disease, as appropriate.
Slovenian: 4.2 Odmerjanje in način uporabe Zdravljenje naj vodijo zdravniki z izkušnjami zdravljenja Gaucherjeve ali Niemann-Pickove bolezni,
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.
Slovenian: http://www.ema.europa.eu.
English: Printing ink shellac glaze iron oxide black (E172) propylene glycol concentrated ammonia solution
Slovenian: propilenglikol, koncentrirana raztopina amoniaka
English: 6.2 Incompatibilities
Slovenian: 6.2 Inkompatibilnosti Navedba smiselno ni potrebna.
English: The recommended starting dose for the treatment of adult patients with Type 1 Gaucher disease is 100 mg three times a day.
Slovenian: Priporočeni začetni odmerek za zdravljenje odraslih bolnikov z Gaucherjevo boleznijo tipa 1 je
English: Warnings and precautions Talk to your doctor or pharmacist before taking Yargesa
Slovenian: Pred začetkom jemanja zdravila Yargesa se posvetujte z zdravnikom ali farmacevtom - če imate ledvično bolezen - če imate jetrno bolezen.
English: The recommended dose for the treatment of adult patients with Niemann-Pick type C disease is 200 mg three times a day.
Slovenian: Običajni odmerek zdravila Yargesa pri odraslih bolnikih je bil 200 mg trikrat dnevno,
English: You must use effective birth control while taking Yargesa.
Slovenian: Med jemanjem zdravila Yargesa morate uporabljati učinkovito metodo preprečitve zanositve.
English: - Keep this leaflet.
Slovenian: PRETISNI OMOT
English: MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE
Slovenian: A. IZDELOVALEC, ODGOVOREN ZA SPROŠČANJE SERIJ B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE C. DRUGI POGOJI IN ZAHTEVE DOVOLJENJA ZA
English: What is in this leaflet
Slovenian: Kaj vsebuje navodilo:
English: Investigations Common
Slovenian: DRUGI PODATKI
English: Yargesa is a white hard capsule that consists of an opaque white cap and body with “708” printed in black on the body.
Slovenian: Izgled zdravila Yargesa in vsebina pakiranja Zdravilo Yargesa je bela trda kapsula, sestavljena iz neprozornega belega pokrovčka in telesa kapsule,
English: Use in patients with severe renal impairment (creatinine clearance < 30 ml/min/1.73 m2) is not recommended (see sections 4.4 and 5.2).
Slovenian: Pri bolnikih s prilagojenim očistkom kreatinina 30-50 ml/min/1,73 m2 uporabo začnemo z odmerkom
English: EU (MA) number Invented name
Slovenian: EU (MA) številka Izmišljeno ime
English: Target species
Slovenian: Ciljna živalska vrsta
English: Packaging Content Package size
Slovenian: Ovojnina Vsebina Velikost pakiranja
English: Strength Pharmaceutical form
Slovenian: Farmacevtska oblika
English: Subcutaneous or intravenus use
Slovenian: Psi in mačke Podkožno ali intravensko dajanje
English: Bottle (Glass with measuring syringe (LDPE)
Slovenian: Viala (steklena) 50 ml
English: Bottle (HDPE) with measuring syringe (LDPE)
Slovenian: Peroralna uporaba Polietilensko vialo visoke gostote + odmerno brizgo
English: Route of administration
Slovenian: Način uporabe zdravila
English: Dogs and cats
Slovenian: Tip I steklena viala
English: Strength Pharmaceutical Form
Slovenian: Jakost Farmacevtska oblika
English: 1 ml (180 µg/ml) 1 vial
Slovenian: 90 µg raztopina za injiciranje napolnjena injekcijska brizga (steklo)
English: Immediate Packaging
Slovenian: Stična ovojnina
English: Route of Administration
Slovenian: 4 viale
English: 8 March 2002 / 20 February 2007
Slovenian: 8. marec 2002 / 20. februar 2007
English: This will prevent infections.
Slovenian: To preprečuje okužbe.
English: 2 years.
Slovenian: 2 leti
English: This is enough for 4 weeks' usage.
Slovenian: Zadostuje za 4 tedne uporabe.
English: Risk Management Plan (RMP)
Slovenian: Načrt za obvladovanje tveganja (RMP)
English: The frequency of these symptoms is not known.
Slovenian: Pogostnost teh simptomov ni znana.
English: If a drop misses your eye, try again.
Slovenian: Če kapljica zgreši oko, poskusite znova.
English: Put your next dose in at the usual time.
Slovenian: Naslednji običajni odmerek vkapajte ob običajnem času.
English: Tilt your head back and look at the ceiling.
Slovenian: Glavo nagnite nazaj in pogled uprite v strop.
English: The following pack sizes are available:
Slovenian: Na voljo so naslednje velikosti pakiranja:
English: • Increased blood pressure
Slovenian: • zvišan krvni tlak
English: For single use only, one container is sufficient to treat both eyes.
Slovenian: Samo za enkratno uporabo, en vsebnik zadostuje za obe očesi.
English: Characteristics in elderly patients
Slovenian: Značilnosti pri starejših bolnikih
English: Liquid is constantly being drained out of the eye and new liquid is made to replace this.
Slovenian: Ta tekočina se nenehno odvaja iz očesa, tvori pa se nova tekočina, ki jo nadomesti.
English: This reduces the pressure inside the eye.
Slovenian: To zmanjšuje tlak znotraj očesa.
English: In addition, monitoring is required with prolonged use in such patients.
Slovenian: Poleg tega je pri daljši uporabi pri teh bolnikih potreben dodaten nadzor.
English: If overdose occurs, treatment should be symptomatic and supportive.
Slovenian: Če se pojavijo znaki prevelikega odmerjanja, naj bo zdravljenje simptomatsko in podporno.
English: Let go of the lower lid, and close your eye for 30 seconds.
Slovenian: Spustite spodnjo veko in zaprite oči za 30 sekund.
English: The requirements for submission of periodic safety update report for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
Slovenian: Zahteve glede predložitve rednega posodobljenega poročila o varnosti zdravila za to zdravilo so določene v seznamu referenčnih datumov EU (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES, in vseh kasnejših posodobitvah, objavljenih na evropskem spletnem portalu o zdravilih.
English: The long term effects of increased iris pigmentation are not known.
Slovenian: Dolgoročni učinki povečane pigmentacije irisa niso znani.
English: Other Information
Slovenian: Druge informacije
English: Increased iris pigmentation is likely to be permanent.
Slovenian: Povečana pigmentacija irisa bo verjetno trajna.
English: If the liquid cannot drain out quickly enough, the pressure inside the eye builds up.
Slovenian: Če tekočina ne more dovolj hitro odtekati, se začne zviševati tlak znotraj očesa.
English: In human blood, bimatoprost resides mainly in the plasma.
Slovenian: V človeški krvi se bimatoprost nahaja predvsem v plazmi.
English: Other medicines and LUMIGAN
Slovenian: Druga zdravila in zdravilo LUMIGAN
English: 4.7 Effects on ability to drive and use machines
Slovenian: 4.7 Vpliv na sposobnost vožnje in upravljanja s strojev
English: You can also report side effects directly via national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of the medicine.
Slovenian: O neželenih učinkih lahko poročate tudi neposredno na nacionalni center za poročanje, ki je naveden v Prilogi V. S tem, ko poročate o neželenih učinkih, lahko prispevate k zagotovitvi več informacij o varnosti tega zdravila.
English: Wash your hands before use.
Slovenian: Pred uporabo si umijte roke.
English: Some of these changes may be permanent, and may lead to differences in appearance between the eyes when only one eye is treated.
Slovenian: Nekatere od teh sprememb so lahko trajne in lahko vodijo do razlik v videzu oči, če je zdravljeno le eno oko.
English: This medicine works by increasing the amount of liquid that is drained.
Slovenian: To zdravilo deluje tako, da povečuje količino tekočine, ki odteka.
English: Do not use more than once a day as the effectiveness of treatment may be reduced.
Slovenian: Ne uporabljajte več kot enkrat dnevno, saj se lahko zmanjša učinkovitost zdravljenja.
English: It is a synthetic prostamide, structurally related to prostaglandin F2 (PGF2), that does not act through any known prostaglandin receptors.
Slovenian: Je sintetični prostamid, strukturno podoben prostaglandinu F2 (PGF2), ki ne deluje preko kateregakoli znanega prostagladinskega receptorja.
English: LUMIGAN has negligible influence on the ability to drive and use machines.
Slovenian: Zdravilo LUMIGAN ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
English: The table also includes those adverse reactions which occurred with both formulations but at a different frequency.
Slovenian: V preglednici so tudi neželeni učinki, ki so se pojavili pri obeh sestavah, vendar različno pogosto.
English: There are no adequate data from the use of bimatoprost in pregnant women.
Slovenian: Ni zadostnih podatkov o uporabi bimatoprosta pri nosečnicah.
English: Your eye contains a clear, watery liquid that feeds the inside of the eye.
Slovenian: Vaše oko vsebuje bistro, vodeno tekočino, ki hrani notranjost očesa.
English: • Worsening of asthma
Slovenian: • poslabšanje astme,
English: • Sensitivity to light
Slovenian: • občutljivost na svetlobo.
English: Warnings and precautions:
Slovenian: Opozorila in previdnostni ukrepi
English: This medicine is for single use only and does not contain preservatives.
Slovenian: To zdravilo je samo za enkratno uporabo, saj ne vsebuje konzervansov.
English: These containers had been inadvertently contaminated by patients who, in most cases, had a concurrent ocular disease.
Slovenian: Te vsebnike so nenamerno okužili bolniki, ki so v večini primerov imeli sočasne očesne bolezni.
English: • Worsening of the lung disease called chronic obstructive pulmonary disease (COPD)
Slovenian: • poslabšanje pljučne bolezni, imenovane kronična obstruktivna pljučna bolezen (KOPB),
English: This medicine may be used on its own or with other drops called beta-blockers which also reduce pressure.
Slovenian: To zdravilo se lahko uporablja samostojno ali z drugimi kapljicami, imenovanimi antagonisti adrenenergičnih receptorjev beta, ki prav tako znižujejo tlak.
English: • An allergic reaction in the eye
Slovenian: • alergijska reakcija v očesu,
English: You should not drive or use machines until your sight is clear again.
Slovenian: Ne vozite in ne uporabljajte strojev, dokler se vam vid ne zbistri.
English: Contact lenses should be removed prior to instillation and may be reinserted 15 minutes following administration.
Slovenian: Kontaktne leče je potrebno pred vkapanjem odstraniti, 15 minut po vkapanju se jih lahko ponovno vstavi.
English: Animal studies have shown reproductive toxicity at high maternotoxic doses (see section 5.3).
Slovenian: Študije na živalih so pri visokih maternotoksičnih odmerkih pokazale vpliv na sposobnost razmnoževanja (glejte poglavje 5.3).
English: Like all medicines, this medicine can cause side effects, although not everybody gets them.
Slovenian: Kot vsa zdravila, ima lahko tudi to zdravilo neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
English: To help you remember, write down the date you opened it in the space on the box.
Slovenian: Da bi se spomnili, si v prostor na škatli zapišite datum, ko ste plastenko odprli.
English: Opened:
Slovenian: Odprto:
English: Pharmacotherapeutic group: Ophthalmologicals, prostaglandin analogues, ATC code: S01EE03.
Slovenian: Farmakoterapevtska skupina: zdravila za očesne bolezni, analogi prostaglandina, Oznaka ATC: S01EE03.
English: Skin
Slovenian: Koža
English: The plasma protein binding of bimatoprost is approximately 88 %.
Slovenian: Plazemski proteini vežejo približno 88 % bimatoprosta.
English: For single use only
Slovenian: samo za enkratno uporabo
English: If you wear contact lenses, take your lenses out before using this medicine.
Slovenian: Če nosite kontaktne leče, jih pred uporabo zdravila odstranite.
English: Periorbital tissue pigmentation has been reported to be reversible in some patients.
Slovenian: Poročali so, da je pigmentacija periorbitalnega tkiva pri nekaterih bolnikih reverzibilna.
English: For any information about this medicine, please contact the local representative of the marketing authorisation holder.
Slovenian: Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika dovoljenja za promet z zdravilom.
English: The prostamide receptor, however, has not yet been structurally identified.
Slovenian: Struktura prostamidnega receptorja še ni odkrita.
English: Gently pull down the lower eyelid until there is a small pocket.
Slovenian: Nežno povlecite spodnjo veko navzdol, dokler ne nastane majhen žepek.
English: • Small breaks in the surface of the eye, with or without inflammation
Slovenian: • majhne razpoke na površini očesa z vnetjem ali brez njega.
English: Animal studies have shown excretion of bimatoprost in breast milk.
Slovenian: Študije na živalih so pokazale, da se bimatoprost izloča v mleko.
English: The following pack sizes are available: cartons containing 1 or 3 bottles of 3 ml solution.
Slovenian: Na voljo so naslednje velikosti pakiranja: škatla, ki vsebuje 1 ali 3 plastenke po 3 ml raztopine.
English: This leaflet is available in all EU/EEA languages on the European Medicines Agency we
Slovenian: To navodilo za uporabo je na voljo v vseh uradnih jezikih EU/EGP na spletni strani Evropske agencije za zdravila.
English: Bimatoprost selectively mimics the effects of newly discovered biosynthesised substances called prostamides.
Slovenian: Bimatoprost selektivno posnema učinke pred kratkim odkritih biosintetiziranih učinkovin, imenovanih prostamidi.
English: - if you have had to stop using eye drops in the past because of a side effect of the preservative benzalkonium chloride.
Slovenian: - če ste v preteklosti morali prenehati uporabljati kapljice za oči zaradi neželenega učinka konzervansa benzalkonijevega klorida.
English: You must throw away the bottle at the latest four weeks after you first opened it, even if there are still some drops left.
Slovenian: Plastenko morate zavreči najpozneje štiri tedne po prvem odprtju, četudi je v njej ostalo še nekaj kapljic.
English: A decision must be made whether to discontinue breastfeeding or to discontinue from LUMIGAN therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.
Slovenian: Treba se je odločiti, ali naj se prekine dojenje ali naj se prekine zdravljenje z zdravilom LUMIGAN, pri tem pa je treba upoštevati koristi dojenja za otroka in koristi zdravljenja z zdravilom LUMIGAN za mater.
English: It is unknown whether bimatoprost is excreted in human breast milk.
Slovenian: Ni znano, ali se bimatoprost izloča v materino mleko pri človeku.
English: Patients with a disruption of the ocular epithelial surface are at greater risk of developing bacterial keratitis.
Slovenian: Pri bolnikih s poškodbo očesne epitelijske površine je nevarnost za pojav bakterijskega keratitisa večja.
English: Patients with hepatic and renal impairment:
Slovenian: Bolniki z okvaro jeter in ledvic:
English: LUMIGAN has not been studied in patients with renal or moderate to severe hepatic impairment and should therefore be used with caution in such patients.
Slovenian: Zdravila LUMIGAN niso preučevali pri bolnikih z ledvično okvaro ali zmerno do hudo okvaro jeter in ga je zato pri takšnih bolnikih potrebno uporabljati previdno.
English: Patients should be instructed to avoid allowing the tip of the dispensing container to contact the eye or surrounding structures, to avoid eye injury and contamination of the solution.
Slovenian: Bolnike je treba opozoriti, da vrh kapalke ne sme priti v stik z očesom ali območjem okoli očesa, zato da se prepreči poškodba očesa in okužba raztopine.
English: • Dry skin
Slovenian: • suha koža,
English: Side effects where the frequency is not known
Slovenian: Neželeni učinki, pri katerih pogostnost ni znana
English: No interaction studies have been performed.
Slovenian: Študij medsebojnega delovanja z drugimi zdravili niso izvedli.
English: You must not use the bottle if the tamper-proof seal on the bottle neck is broken before you first use it.
Slovenian: Plastenke ne smete uporabljati, če je pečat zaščitne zaporke na vratu plastenke pred prvo uporabo poškodovan.
English: Thus, it is important to apply LUMIGAN as instructed and avoid it running onto the cheek or other skin areas.
Slovenian: Zato je treba zdravilo LUMIGAN uporabljati v skladu z navodili in preprečiti, da steče na lica ali druge predele kože.
English: This medicine does not contain a preservative.
Slovenian: To zdravilo ne vsebuje konzervansov.
English: Benzalkonium chloride, which is commonly used as a preservative in ophthalmic products, has been reported to cause punctate keratopathy and/or toxic ulcerative keratopathy.
Slovenian: Za benzalkonijev klorid, ki se običajno uporablja v očesnih zdravilih kot konzervans, obstajajo poročila, da povzroča točkasto keratopatijo in/ali toksično ulcerozno keratopatijo.
English: On combining the data from phase III monotherapy and adjunctive LUMIGAN 0.3 mg/ml eye drops, solution usage, the most frequently reported treatment-related adverse events were: growth of eyelashes in up to 45% in the first year with the incidence of new reports decreasing to 7% at 2 years and 2% at 3 years, conjunctival hyperaemia (mostly trace to mild and thought to be of a noninflammatory nature) in up to 44% in the first year with the incidence of new reports decreasing to 13% at 2 years and 12% at 3 years and ocular pruritus in up to 14% of patients in the first year with the incidence of new reports decreasing to 3% at 2 years and 0% at 3 years.
Slovenian: S kombinacijo podatkov iz III. faze monoterapije in adjuvantne terapije z zdravilom LUMIGAN 0,3 mg/ml kapljice za oko, raztopina, so bila najpogostejša poročila o neželenih učinkih, kot posledica zdravljenja: rast trepalnic pri do 45 % bolnikov v prvem letu, z upadom števila novih poročil na 7 % pri 2 letih in 2 % pri 3 letih, hiperemija veznice (najpogosteje komaj opazna do blaga in domnevno nevnetnega izvora) pri do 44 % bolnikov v prvem letu, z upadom števila novih poročil na 13 % pri 2 letih in na 12 % pri 3 letih in okularni puritus pri do 14 % bolnikov v prvem letu, z upadom števila novih poročil na 3 % pri 2 letih in 0 % pri 3 letih.
English: EXP Once the pouch is opened, the single dose containers should be used within 30 days.
Slovenian: EXP Ko je vrečka odprta, enoodmerne vsebnike porabite v 30 dneh.
English: Carton containing 30 or 90 single-dose containers in three or nine aluminium foil pouches, respectively.
Slovenian: Škatla, ki vsebuje 30 ali 90 enoodmernih vsebnikov v treh ali devetih vrečkah iz aluminijaste folije.
English: 4 weeks after first opening.
Slovenian: 4 tedne po prvem odprtju.
English: Fertility There are no data on the effects of bimatoprost on human fertility.
Slovenian: Plodnost Ni podatkov o učinkih bimatoprosta na plodnost pri ljudeh.
English: Take one single-dose container from the pouch and hold it upright (with the cap pointing upwards) and twist off the cap.
Slovenian: Vzemite en enoodmerni vsebnik iz vrečke ter ga držite pokončno (da je pokrovček obrnjen navzgor) in pokrovček odstranite tako, da ga zasukate.
English: Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use.
Slovenian: V nekliničnih študijah so zabeležili učinke le pri izpostavljenosti, ki naj bi znatno presegala maksimalno izpostavljenost pri človeku, kar kaže, da je to za klinično uporabo manj pomembno.
English: Wait 15 minutes after using the drops, and before you put your lenses back in.
Slovenian: Po uporabi kapljic počakajte 15 minut, preden si ponovno vstavite leče.
English: These doses resulted in systemic exposures of at least 33- or 97-times higher, respectively, than the intended human exposure.
Slovenian: Pri teh odmerkih je prišlo do najmanj 33- oz. 97-krat večje sistemske izpostavljenosti kot pri priporočeni uporabi pri človeku.
English: Affecting the body
Slovenian: Učinki na telo:
English: The mechanism of action by which bimatoprost reduces intraocular pressure in humans is by increasing aqueous humour outflow through the trabecular meshwork and enhancing uveoscleral outflow.
Slovenian: Mehanizem delovanja, s katerim bimatoprost znižuje zvišan očesni tlak pri ljudeh, je s povečanjem iztekanja prekatne vodice skozi trabekularno omrežje in povečanje uveoskleralnega iztekanja.
English: As with any ocular treatment, if transient blurred vision occurs at instillation, the patient should wait until the vision clears before driving or using machines.
Slovenian: Tako kot pri ostalih zdravljenjih oči morajo bolniki, če se jim po vkapanju pojavi začasno zamegljen vid, počakati z vožnjo ali upravljanjem s stroji, dokler se vid ne zbistri.
English: Iris colour changes seen with ophthalmic administration of bimatoprost may not be noticeable for several months to years.
Slovenian: Spremembe barve irisa ob uporabi bimatoprosta lahko ne zaznamo nekaj mesecev ali let.
English: If you are pregnant or breast-feeding, think you might be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Slovenian: Če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte z zdravnikom ali farmacevtom, preden vzamete to zdravilo.